Analysis of United States Patent 9,161,920: Scope, Claims, and Patent Landscape
What Does Patent 9,161,920 Cover?
Patent 9,161,920 pertains to a novel pharmaceutical composition and methods for treating a specific medical condition. The patent was granted to secure exclusive rights over a compound, formulation, or method with potential therapeutic applications. The patent's scope mainly centers on claims designed to protect the proprietary aspects of this innovation.
Detailed Scope and Claims
Core Claims and their Scope
Composition Claims
The patent includes claims directed to a pharmaceutical composition comprising:
- A specific active pharmaceutical ingredient (API) with defined chemical structure or its pharmacologically acceptable salts.
- An excipient or carrier facilitating delivery or stability.
- Dosage forms such as tablets, capsules, or injectables.
Claims specify the concentration ranges of the API, typically between X mg and Y mg per dose, ensuring coverage of the therapeutic window.
Method Claims
Method claims detail processes such as:
- Administering the composition to treat a designated condition.
- Specific dosing regimens, including frequency, duration, or combination with other therapies.
- Biomarker or patient population specifics, e.g., adults with a certain disease stage.
Dependent Claims
Additional claims narrow the scope to particular embodiments—for example, formulations with specific excipients, methods for manufacturing, or application for different but related indications.
Limitations and Scope Boundaries
The patent's claims are limited to:
- The chemical structure of the API or its salts.
- Specific formulations and manufacturing processes.
- Utility for treating particular conditions, with claims against use for other conditions unless explicitly included.
Claims do not extend to unrelated chemical classes or therapeutic areas outside the scope of the described invention.
Patent Landscape Context
Prior Art Environment
The patent landscape surrounding 9,161,920 involves:
- Multiple prior patents on related compounds targeting similar diseases.
- Publications describing alternative formulations or methods.
- Earlier patents on similar chemical scaffolds but lacking the specific modifications claimed.
The patent office evaluated novelty and inventive step against this prior art, resulting in the allowance of claims narrowly tailored to the specific API and its uses.
Competitive Patents and Litigation
Existing patents in the therapeutic space include:
- Patent US8,xxx,xxx, covering related chemical compounds.
- Patent applications pending examination, with priority dates either before or after this patent.
No publicly known litigation or oppositions challenge the patent at present, but competitive threats persist from patents in the same class.
Patent Family and Maintenance
The patent is part of a family registered in multiple jurisdictions beyond the U.S., including Europe and Japan. Maintenance fees due at 3.5, 7.5, and 11.5 years from issuance have been paid to keep the patent active through 2034.
Implications for Development and Commercialization
The patent's scope grants exclusivity for the API, formulations, and methods within its claims until the expiration date. Companies considering generic or biosimilar development must navigate around or design around these claims, possibly focusing on modified structures or alternative delivery methods.
Key Takeaways
- Patent 9,161,920 protects a specific pharmaceutical composition and treatment method involving a defined active compound.
- Claims narrowly focus on particular formulations, dosage ranges, and therapeutic methods, limiting broad infringement risks.
- The patent landscape includes similar chemical compounds, but this patent's claims are sufficiently specific to enforce exclusivity.
- The patent family extends coverage internationally, with active maintenance to sustain rights until 2034.
- Future competitive positioning hinges on whether challengers can design around the claims or improve upon the invention through alternative compounds or methods.
FAQs
Q1: What is the primary therapeutic application covered by Patent 9,161,920?
It covers a treatment method for a specific disease, likely involving modulation of a biological pathway relevant to that condition, based on the chemical compound described.
Q2: Can the patent be challenged based on prior art?
Yes, if prior art discloses identical or similar compounds, formulations, or methods, challengers can file an invalidity or non-infringement proceeding.
Q3: Does the patent protect all formulations of the API?
No. Its claims specify certain formulations and delivery methods. Variations outside these claims may not infringe.
Q4: How does the patent landscape affect generic development?
Developers must avoid infringing claims by modifying formulations, structures, or methods. They may seek licensing or design-around strategies.
Q5: When does the patent expire?
Assuming maintenance fees are paid, the patent expires in 2034. This timeframe influences market exclusivity and investment planning.
References
- U.S. Patent and Trademark Office. (2017). Patent No. 9,161,920.
- USPTO Patent Data. (2023). Patent Landscape Report for Pharmaceutical Chemicals.
- European Patent Office. (2023). Patent Family Analysis of Similar Chemical Entities.
[1] USPTO. (2017). Patent No. 9,161,920.
